Suzhou Sepax Technologies Overview
- Year Founded
-
2002
- Status
-
Public
- Employees
-
417
- Stock Symbol
-
688758
- Investments
-
1
- Share Price
-
$3.38
- (As of Friday Closing)
Suzhou Sepax Technologies General Information
Description
Suzhou Sepax Technologies Co Ltd is engaged in the Research, development and produce liquid chromatography materials for drug analysis, detection, separation and purification.
Contact Information
Website
www.sepax-tech.comCorporate Office
- 5 Innovation Way
- Newark, DE 19711
- United States
Corporate Office
- 5 Innovation Way
- Newark, DE 19711
- United States
Suzhou Sepax Technologies Stock Performance
As of 13-Nov-2026, Suzhou Sepax Technologies’s stock price is $3.38. Its current market cap is $1.41B with 416M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $3.38 | $3.57 | $2.30 - $5.19 | $1.41B | 416M | 10.7M | $0.07 |
Suzhou Sepax Technologies Financials Summary
As of 30-Sep-2026, Suzhou Sepax Technologies has a trailing 12-month revenue of $76.2M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 1,802,198 | 1,015,304 | ||
| Revenue | 76,236 | 56,030 | 43,964 | 34,659 |
| EBITDA | 31,212 | 20,817 | 14,621 | 9,310 |
| Net Income | 28,748 | 17,596 | 11,868 | 7,419 |
| Total Assets | 250,052 | 207,683 | 161,958 | 155,460 |
| Total Debt | 19,939 | 7,940 | 6,008 | 6,910 |
Suzhou Sepax Technologies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Suzhou Sepax Technologies Comparisons
Industry
Financing
Details
Suzhou Sepax Technologies Competitors (3)
One of Suzhou Sepax Technologies’s 3 competitors is Meso Scale Diagnostics, a Corporation company based in Rockville, MD.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Meso Scale Diagnostics | Corporation | Rockville, MD | ||||
| Qiagen | Formerly VC-backed | Hilden, Germany | ||||
| Phenomenex | Corporate Backed or Acquired | Torrance, CA |
Suzhou Sepax Technologies Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Suzhou Sepax Technologies Patents
Suzhou Sepax Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022252071-A1 | A synthetic polymeric porous medium with hierarchical multiple layer structure, its design, synthesis, modification, and liquid chromatographic applications | Inactive | 31-May-2021 | ||
| WO-2021248302-A1 | Chromatography medium for separating boron-containing substances | Inactive | 09-Jun-2020 | ||
| US-7303821-B1 | Coating of an addition block copolymer coupled to the support by a polymer having a hydrocarbon backbone with functional groups that bind onto the support surface and functional groups that generate a living radical for initiating polymerization of addition monomers; electrophoretic separators | Inactive | 24-Jul-2003 | ||
| US-7247387-B1 | Uniform and hydrophilic coating on the contact lens surface to render bio-compatibility and suppress bindings of proteins, bacteria or other biological entities | Inactive | 24-Jul-2003 | C09D133/26 |
Suzhou Sepax Technologies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Suzhou Sepax Technologies Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Suzhou Sepax Technologies Investments (1)
Suzhou Sepax Technologies’s most recent deal was a Early Stage VC with MoleculeMind for . The deal was made on 17-Jun-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| MoleculeMind | 17-Jun-2026 | Early Stage VC | Discovery Tools (Healthcare) |
Suzhou Sepax Technologies ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
Suzhou Sepax Technologies FAQs
-
When was Suzhou Sepax Technologies founded?
Suzhou Sepax Technologies was founded in 2002.
-
Where is Suzhou Sepax Technologies headquartered?
Suzhou Sepax Technologies is headquartered in Newark, DE.
-
What is the size of Suzhou Sepax Technologies?
Suzhou Sepax Technologies has 417 total employees.
-
What industry is Suzhou Sepax Technologies in?
Suzhou Sepax Technologies’s primary industry is Discovery Tools (Healthcare).
-
Is Suzhou Sepax Technologies a private or public company?
Suzhou Sepax Technologies is a Public company.
-
What is Suzhou Sepax Technologies’s stock symbol?
The ticker symbol for Suzhou Sepax Technologies is 688758.
-
What is the current stock price of Suzhou Sepax Technologies?
As of 13-Nov-2026 the stock price of Suzhou Sepax Technologies is $3.38.
-
What is the current market cap of Suzhou Sepax Technologies?
The current market capitalization of Suzhou Sepax Technologies is $1.41B.
-
What is Suzhou Sepax Technologies’s current revenue?
The trailing twelve month revenue for Suzhou Sepax Technologies is $76.2M.
-
Who are Suzhou Sepax Technologies’s competitors?
Meso Scale Diagnostics, Qiagen, and Phenomenex are competitors of Suzhou Sepax Technologies.
-
What is Suzhou Sepax Technologies’s annual earnings per share (EPS)?
Suzhou Sepax Technologies’s EPS for 12 months was $0.07.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
